Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-22 Sale |
2024-03-22 4:55 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
406,670 | $0 | $0 | 0 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-11 7:03 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $20 | $1,297,170 | 171,301 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-14 6:00 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $15.89 | $1,030,660 | 236,166 (Direct) |
View |
| 2023-10-09 Sale |
2023-10-10 5:04 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $14.2 | $921,286 | 301,029 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 08:14 am |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
51,301 | $1.95 | $100,037 | 171,301 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-01-29 |
Tvardi Therapeutics Inc. | TVRD | Shah Sujal Director |
18,441 | $0 | 18,441 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
14,372 | $8.43 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A 2025-01-06 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
139,119 | $0 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
11,649 | $10 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
14,625 | $1.06 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
52,084 | $1.72 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
22,076 | $4.05 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
2,288 | $5.78 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
3,125 | $11.69 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
1 | $2.94 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
18,899 | $9.21 | 455,314 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:27 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
453,750 | $0 | 625,051 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:03 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $0 | 171,301 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $5 | 171,301 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:00 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $0 | 236,166 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:00 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $5 | 236,166 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 5:04 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $0 | 301,029 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 5:04 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $5 | 301,029 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:27 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:55 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
650,000 | $0 | 650,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 2:56 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
287,000 | $0 | 287,000 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:12 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal President & CEO |
558,108 | $0 | 558,108 (Direct) |
View |